PubMed Health⌕ Search

Biomedical subjects

John O'Reilly

Publications and source records attributed to John O'Reilly.

11 recordsLinked to original sources
PubMed2006

Three adults with acute lymphoblastic leukemia and dic(7;9)(p11.2;p11).

We report the cases of three adults with acute lymphoblastic leukemia (ALL) who had a dic(7;9)(p11.2;p11) on the diagnostic bone marrow cytogenetic analysis. All three were males with B-ALL (aged 25, 38, and 48 years) who at presentation had 90-100% replacement of marrow with lymphoblasts. One patient died 23 months post induction therapy, which was 9 months post allogeneic stem cell transplantation (SCT); as of writing, the other two patients were in remission and well, one of them at 4 years after SCT and the other at 7.5 years without SCT. To our knowledge, these cases are the first reported in adult ALL with dic(7;9) and demonstrate a consistent phenotype, with good initial response to therapy but variable long-term outcome.

Adult↗
PubMed2005

Equilibrium in-fibre standardisation technique for solid-phase microextraction.

This note describes a fundamental investigation into solid-phase microextraction (SPME) using a standard loaded into the fibre coating as a means of internal standardisation for the analysis of samples contained in vials. The loading of reproducible amounts of standards into a non-porous SPME fiber was investigated. It was found that spiking low milligram quantities of standards such as benzene, toluene, ethylbenzene, xylenes (BTEX) and/or naphthalene into a few grams of pump oil sealed in a 20 mL vial provided an excellent standard generator. A single solution allowed over a hundred standard loadings with a reproducibility of <4% R.S.D. When a fiber, loaded with the standard(s) was introduced into a sample vial, extraction of analytes into the fiber and desorption of the standard(s) into the sample matrix occur simultaneously. Quantification was then based on the equilibrium distribution of the standards and the analytes between the fibre coating and the sample matrix in the vial. A comparison of equilibration profiles obtained using traditional internal standardisation and the in-fibre approach generally showed the same equilibration behaviour. The developed method was successfully used to correct for matrix effects in the BTEX analysis of a wine sample.

Automation↗
PubMed2005

Determination of low-molecular mass aldehydes by automated headspace solid-phase microextraction with in-fibre derivatisation.

Headspace solid-phase microextraction (HS-SPME) analysis of low-molecular mass (C1-C10) aldehydes in aqueous solutions was investigated, using pentafluorophenylhydrazine (PFPH) and o-2,3,4,5,6-(pentafluorobenzyl)hydroxylamine hydrochloride (PFBHA) as in-fibre derivatisation reagents. Analysis of the derivatives was achieved, using GC-flame ionisation detection (FID). A comparison of the two reagents showed that PFBHA was superior to PFPH under the investigated conditions. Fundamental studies of the PFBHA and PFPH reactions showed that the kinetics of the process was limited by the mass transport rate of the analytes to the fibre. The developed PFBHA method gave detection limits in the low to sub-microgram per litre range for most of the aldehydes tested. The method was applied successfully to the analysis of particleboard, wine and fish samples.

Aldehydes↗
PubMed2005

Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder.

We report a patient with an unclassifiable myeloproliferative disorder and the rare t(X;20)(q13;q13.3) as the sole cytogenetic abnormality. The breakpoint on Xq is consistent with other reports of translocations involving the X chromosome with breakpoints that cluster to Xq13 and association with myeloid disorders. Late replication studies demonstrated the inactive X chromosome was involved in this translocation. The critical event in patients with myeloproliferative disease and deletion of 20q appears to be the loss of tumor suppressor genes. This may also be the mechanism in this patient with a potential cryptic deletion associated with the translocation. Alternatively, spreading of X inactivation into the derivative chromosome 20 provides a second mechanism for the loss of function of tumor suppressor genes on 20q. The finding in this patient of t(X;20) together with three others reported in the literature indicates that this may represent a primary non-random abnormality associated with myeloid malignancy, which may take on clinical significance with the accumulation of more cases.

Chromosomes, Human, Pair 20↗
PubMed2005

Direct electrochemical interaction between a modified gold electrode and a bacterial membrane extract.

A novel electrochemical approach is described for redox-active membrane proteins. A total membrane extract (in the form of vesicles) of Bacillus subtilis is tethered onto gold surfaces modified with cholesterol based thiols. The membrane vesicles remain intact on the surface and do not rupture or fuse to form a planar bilayer. Oxidation/reduction signals are obtained of the natural co-enzyme, menaquinone-7, located in the membrane. The membrane protein, succinate menaquinone oxidoreductase (SQR), remains in the vesicles and is able to reduce fumarate using menaquinone as mediator. The catalysis of the reverse reaction (oxidation of succinate), which is the natural catalytic function of SQR, is almost absent with menaquinone. However, adding the co-enzyme ubiquinone, which has a reduction potential that is about 0.2 V higher, restores the succinate oxidation activity.

Bacillus subtilis↗
PubMed2004

Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16.

Acute myelomonocytic leukemia with bone marrow eosinophilia (AML M4Eo) is a subtype of AML with distinct morphological features. Inversion (16)(p13.1q22), t(16;16)(p13.1;q22), and del(16)(q22) are nonrandom abnormalities associated with AML M4Eo and a favorable prognosis, compared with the standard risk group for AML. Deletions of the proximal region of the MYH11 gene located at 16p13.1 have been detected in about 20% of patients with inv(16), with an undetermined effect on patient survival. We present the case of a patient with AML M4Eo and inversion 16 with a distal deletion of the CBFB gene at 16q22 detected with fluorescence in situ hybridization. To our knowledge, only one previous report of a similar deletion has appeared in the literature.

Adolescent↗
PubMed2004

Low 13C-background for NMR-based studies of ligand binding using 13C-depleted glucose as carbon source for microbial growth: 13C-labeled glucose and 13C-forskolin binding to the galactose-H+ symport protein GalP in Escherichia coli.

Obtrusive 13C-backgrounds can be a problem in 13C NMR-based studies of ligand binding to bacterial membrane transport proteins in their natural state in inner membranes. This is largely solved for the bacterial galactose-H+ symport protein GalP by growing the producing organism Escherichia coli on 13C-depleted glucose (13C </= 0.07%) as the main carbon source. 13C solid-state NMR-based binding studies for the inhibitor forskolin 1 and the transported substrate glucose 2, both singly labeled with 13C, are reported and discussed. For 1, tight binding is observed, while for 2, significant exchange takes place during the time scale of the NMR experiment.

Calcium-Binding Proteins↗
PubMed2003

Collection and characterisation of bacterial membrane proteins.

A general strategy for the amplified expression in Escherichia coli of membrane transport and receptor proteins from other bacteria is described. As an illustration we report the cloning of the putative alpha-ketoglutarate membrane transport gene from the genome of Helicobacter pylori, overexpression of the protein tagged with RGS(His)6 at the C-terminus, and its purification in mg quantities. The retention of structural and functional integrity was verified by circular dichroism spectroscopy and reconstitution of transport activity. This strategy for overexpression and purification is extended to additional membrane proteins from H. pylori and from other bacteria.

Bacterial Proteins↗
PubMed2003

Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria.

Alternative splicing of the ketohexokinase (fructokinase) gene generates a "central" predominantly hepatic isoform (ketohexokinase-C) and a more widely distributed ketohexokinase-A. Only the abundant hepatic isoform is known to possess activity, and no function is defined for the lower levels of ketohexokinase-A in peripheral tissues. Hepatic ketohexokinase deficiency causes the benign disorder essential fructosuria. The molecular basis of this has been defined in one family (compound heterozygosity for mutations Gly40Arg and Ala43Thr). Here we show that both ketohexokinase isoforms are indeed active. Ketohexokinase-A has much poorer substrate affinity than ketohexokinase-C for fructose but is considerably more thermostable. The Gly40Arg mutation seems null, rendering both ketohexokinase-A and ketohexokinase-C inactive and largely insoluble. The Ala43Thr mutant retains activity, but this mutation decreases the thermal stability of both ketohexokinase-A and ketohexokinase-C. At physiologic temperature, this results in significant loss of ketohexokinase-C activity but not of ketohexokinase-A. Affected individuals who carry both mutations therefore probably have a selective deficiency of hepatic ketohexokinase, with peripheral ketohexokinase-A being preserved. These findings raise the possibility that ketohexokinase-A serves an unknown physiologic function that remains intact in essential fructosuria. Further mutation analysis in this rare disorder could illuminate the question of whether ketohexokinase-A activity is, unlike that of ketohexokinase-C, physiologically indispensable.

Alternative Splicing↗